Michael Kalos

Pillar College — United States

Medicine · Health Sciences

54h-index26.0kcitations244works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(127), Immunotherapy and Immune Responses(94), Cancer Immunotherapy and Biomarkers(66), Immune Cell Function and Interaction(34), Monoclonal and Polyclonal Antibodies Research(26)

Publications243 total

Going with the Flow: Circulating Tumor-Reactive Lymphocytes Stream into Cancer Therapy
Clinical Cancer Research·2025
401 Anti-tumor activity of circulating tumor reactive lymphocytes (cTRLs) isolated from checkpoint-refractory melanoma patients that failed TIL manufacturing
Regular and Young Investigator Award Abstracts·2024Open Access
400 Circulating tumor reactive lymphocytes (cTRLs) isolated from colorectal cancer (CRC) patients are reactive against autologous tumors and show less exhaustion than tumor-infiltrating lymphocytes (TILs)
Regular and Young Investigator Award Abstracts·2024Open Access
Accelerating the development of genetically engineered cellular therapies: a framework for extrapolating data across related products
Cytotherapy·2024· 2 citedOpen Access
Data from Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity
2023Open Access
Supplementary Data File from Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity
2023Open Access
Data from Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity
2023Open Access
Supplementary Data File from Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity
2023Open Access
Figure S8 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Figure S6 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Figure S9 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Figure S3 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Supplementary Materials and Methods from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Table S1 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Data from Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies
2023Open Access
Figure S1 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Supplementary Materials and Methods from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Figure S4 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Table S1 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Figure S7 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
page 1 of 13Next →

Frequent Co-authors

Carl H. June(26), Bruce L. Levine(16), Stephan A. Grupp(7), Yangbing Zhao(7), David L. Porter(6), Gwendolyn Binder-Scholl(6), Gabriela Plesa(5), Marcela V. Maus(5), Bent K. Jakobsen(5), Simon F. Lacey(5), Carmine Carpenito(5), Sylvia Janetzki(5), Cedrik M. Britten(5), Holden T. Maecker(5), Pedro Romero(5), Axel Hoos(5), Edward A. Stadtmauer(4), Aaron P. Rapoport(4), Namir J. Hassan(4), John Scholler(4)